Infectious complications of pacemaker implantation are not common but
may be particularly severe. Localised wound infections at the site of
implantation have been reported in 0.5 % of cases in the most recent s
eries with an average of about 2 %. The incidence of septicaemia and i
nfectious endocarditis is lower, about 0.5 % of cases. The operator's
experience, the duration of the procedure and repeat procedures are co
nsidered to be predisposing factors. The main cause of these infection
s is though to be local contamination during the implantation. The com
monest causal organism is the staphylococcus (75 to 92 %), the staphyl
ococcus aureus being the cause of acute infections whereas the staphyl
ococcus epidermis is associated with cases of secondary infection. The
usual clinical presentation is infection at the site of the pacemaker
but other forms such as abscess, endocarditis, rejection of the impla
nted material, septic emboli and septic phlebitis have been described.
The diagnosis is confirmed by local and systemic biological investiga
tions and by echocardiography (especially transoesophageal echocardiog
raphy) in cases of right heart endocarditis. There are two axes of tre
atment : bactericidal double antibiotherapy and surgical ablation of t
he infected material either percutaneously or by cardiotomy. Though co
ntroversial, and unsupported by scientific evidence, the role of syste
matic, preoperative, prophylactic antibiotic therapy in the prevention
of these complications seems to be increasing.